103 structural-engineering "https:" "https:" "https:" "https:" "https:" "https:" "Multiple" "https:" positions at Ulster University
Sort by
Refine Your Search
-
on digital health technology derived endpoints https://www.sciencedirect.com/science/article/pii/S1359644625001011 (opens in new window) https://www.sciencedirect.com/science/article/pii/S1359644625001011
-
qubits. Using software such as Qiskit Metal and Ansys, qubit designs will be constructed and simulated, with AI methods optimizing them to explore the trade-offs between multiple design objectives. It is
-
already allocated to someone who was ranked higher than you, you may be offered your 2nd or 3rd choice project depending on the availability of this project. A degree in Science or Engineering (e.g
-
bridge the gap between treatment technology, data acquisition systems, and user experience – and to support transition of buildings to net-zero carbon targets. This PhD project will tackle that challenge
-
reading Activity Alliance, 2020. My Active Future: Including Every Child. Available at: https://www.activityalliance.org.uk/how-we-help/research/5658-my-active-future-including-every-child-march-2020
-
structures impacting the safety of women and girls in society, both through its methodology and analysis. Set within the context of Northern Ireland, a country in which a notable majority of women and girls
-
', Department for Agriculture, Environment and Rural Affairs, Published 16 December 2013, [Online] Available at: https://www.daera-ni.gov.uk/publications/review-waste-disposal-mobuoy-site-and-lessons-learnt
-
Apply and key information This project is funded by: Department for the Economy (DfE) Summary Transform how we determine biomolecular structures. This PhD develops generative AI tools that use
-
in Gait Training. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 24(11), https://doi.org/10.1109/TNSRE.2016.2551642 * Friston, FitzGerald, Rigoli, Schwartenbeck & Pezzulo (2017
-
lack of specificity and relatively short half-life. Application of new technology to the production of monoclonal antibodies to the GIP receptor which antagonise GIP action overcomes these difficulties